CN114404461A - Processing method of wall-broken ganoderma lucidum spore powder - Google Patents

Processing method of wall-broken ganoderma lucidum spore powder Download PDF

Info

Publication number
CN114404461A
CN114404461A CN202210120270.0A CN202210120270A CN114404461A CN 114404461 A CN114404461 A CN 114404461A CN 202210120270 A CN202210120270 A CN 202210120270A CN 114404461 A CN114404461 A CN 114404461A
Authority
CN
China
Prior art keywords
ganoderma lucidum
container
spore powder
lucidum spore
wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210120270.0A
Other languages
Chinese (zh)
Inventor
黄江南
许东
黄晓辉
谭震
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUNAN EDIBLE FUNGI RESEARCH INSTITUTE
Hunan Zhiyangtang Biotechnology Co ltd
Central South University of Forestry and Technology
Original Assignee
HUNAN EDIBLE FUNGI RESEARCH INSTITUTE
Hunan Zhiyangtang Biotechnology Co ltd
Central South University of Forestry and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUNAN EDIBLE FUNGI RESEARCH INSTITUTE, Hunan Zhiyangtang Biotechnology Co ltd, Central South University of Forestry and Technology filed Critical HUNAN EDIBLE FUNGI RESEARCH INSTITUTE
Priority to CN202210120270.0A priority Critical patent/CN114404461A/en
Publication of CN114404461A publication Critical patent/CN114404461A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Zoology (AREA)
  • Insects & Arthropods (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides a processing method of wall-broken ganoderma lucidum spore powder, which comprises the following steps: dissolving 10-20g of wall-broken ganoderma lucidum spore powder in 100mL of warm water in a container A, heating to boil, cooling to 70-75 ℃ at room temperature, centrifuging and sucking supernatant into a container B; placing the precipitate in a container A, adding 90-100mL warm water, stirring, cooling to room temperature, and adding 2-5g porous starch to adsorb triterpenes to the porous starch; pouring 1-2g of soluble dietary fiber and 0.2-1ml of honey into the supernatant in the container B, and stirring until the honey is completely dissolved; cooling the honey water in the container B to room temperature, pouring the honey water into the container A, and uniformly stirring; drying and granulating the suspension to prepare the bitter-free ganoderma lucidum spore powder. According to the processing method of the wall-broken ganoderma lucidum spore powder, the porous starch is adopted to wrap the triterpenoids so as to remove the bitter taste of the prepared wall-broken ganoderma lucidum spore powder, and meanwhile, the porous starch is easy to degrade, so that the digestion and absorption effects of the wall-broken ganoderma lucidum spore powder in intestinal tracts are improved.

Description

Processing method of wall-broken ganoderma lucidum spore powder
Technical Field
The invention relates to the technical field of ganoderma lucidum spore powder processing, in particular to a processing method of wall-broken ganoderma lucidum spore powder.
Background
Ganoderma lucidum is fruiting body of Ganoderma lucidum or Ganoderma sinense belonging to Polyporaceae, and is a medicinal and edible fungus with high demand worldwide. Because of its high potency, the medicine is called "Xiancao", the history of using ganoderma lucidum in our country has been over 4000 years.
The Ganoderma spore powder is egg-shaped germ cell with size of 4-6 μm ejected from the fungus tube after Ganoderma fruiting body grows and matures. The yield of each fruit body is different and can reach 10g maximally. Many researches show that the ganoderma lucidum spore powder and the extract thereof have the value of reanalyzing bioactivity, can regulate the immunity of human bodies, inhibit and even kill tumors, have the functions of resisting oxidation and preventing aging, and have good treatment effect on systemic diseases such as allergy, insomnia and the like. However, the outer layer of ganoderma lucidum spores has a hard chitin double-wall structure, which limits digestion and absorption. In recent years, with the development of novel process technology, wall-broken ganoderma lucidum spore powder produced by adopting a wall-breaking technology is popular because of good health-care and medicinal effects. However, the wall-broken ganoderma lucidum spore powder also has certain defects, namely, the bitter taste is more prominent after the wall breaking, and the taste is poorer, mainly because the ganoderma lucidum spore powder contains triterpenes bitter substances.
In view of the above, there is a need to provide a new processing technology of ganoderma lucidum spore powder to solve the above technical problems.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a processing method of wall-broken ganoderma lucidum spore powder, wherein porous starch is adopted to wrap triterpenoids so as to remove the bitter taste of the prepared wall-broken ganoderma lucidum spore powder, and meanwhile, the porous starch is easy to degrade, so that the digestion and absorption effects of the wall-broken ganoderma lucidum spore powder in intestinal tracts are improved.
In order to solve the problems, the technical scheme of the invention is as follows:
a processing method of wall-broken ganoderma lucidum spore powder comprises the following steps:
step S1, dissolving 10-20g of wall-broken ganoderma lucidum spore powder in 100mL of warm water in a container A, heating to boiling after stirring, keeping for 2-3min under the boiling condition, cooling to 70-75 ℃ at room temperature, centrifuging for 5-8min at the rotating speed of 3000rpm, and sucking supernatant into a container B;
step S2, placing the precipitate in a container A, adding 90-100mL of warm water, stirring, cooling to room temperature, adding 2-5g of porous starch, and stirring for 5-10min to enable the triterpenoids to be adsorbed to the porous starch;
step S3, pouring 1-2g of soluble dietary fiber and 0.2-1ml of honey into the supernatant in the container B, and stirring until the honey is completely dissolved;
step S4, cooling the honey water in the container B to room temperature, pouring the honey water into the container A, and uniformly stirring;
and step S5, drying and granulating the suspension to obtain the bitter-free ganoderma lucidum spore powder.
Further, the processing method of the wall-broken ganoderma lucidum spore powder comprises the following steps:
step S1, dissolving 10g of wall-broken ganoderma lucidum spore powder in 100mL of warm water in a container A, stirring, heating to boil, keeping for 2min under boiling condition, cooling to 70 ℃ at room temperature, centrifuging for 5min at 3000rpm, and absorbing supernatant into a container B;
step S2, placing the precipitate in a container A, adding 90mL of warm water, stirring, cooling to room temperature, adding 2g of porous starch, and stirring for 5min to enable the triterpenoids to be adsorbed to the porous starch;
step S3, pouring 1g of soluble dietary fiber and 0.2-1ml of honey into the supernatant in the container B, and stirring until the honey is completely dissolved;
step S4, cooling the honey water in the container B to room temperature, pouring the honey water into the container A, and uniformly stirring;
and step S5, drying and granulating the suspension to obtain the bitter-free ganoderma lucidum spore powder.
Compared with the prior art, the processing method of the wall-broken ganoderma lucidum spore powder has the beneficial effects that:
according to the processing method of the wall-broken ganoderma lucidum spore powder, porous starch is adopted to wrap triterpenoids in the ganoderma lucidum spore powder, wherein the porous starch has large specific surface area and specific pore volume and good water and oil absorption performance, and bitter triterpenoids in the ganoderma lucidum spore powder have hydrophobicity and can be better wrapped in the porous starch. The porous starch wraps bitter triterpenes, so that the direct action of bitter components of the wall-broken ganoderma spore powder and oral cavity can be reduced, and the bitter taste is reduced.
Secondly, according to the processing method of the wall-broken ganoderma lucidum spore powder, porous starch is adopted to wrap triterpenoids in the ganoderma lucidum spore powder, wherein the porous starch has a natural degradation effect, and the wrapped wall-broken ganoderma lucidum spore powder is orally taken, so that the porous starch is digested in intestinal tracts, active ingredients of the ganoderma lucidum spore powder are well digested and absorbed in the intestinal tracts, and the health care effect of the ganoderma lucidum spore powder is improved.
Third, the processing method of the wall-broken ganoderma lucidum spore powder provided by the invention adds the soluble dietary fiber and the honey to adjust the taste of the ganoderma lucidum spore powder, has the effect of relaxing bowel, and can well overcome the constipation phenomenon of some people by being compatible with the ganoderma lucidum spore powder.
Detailed Description
The following description of the present invention is provided to enable those skilled in the art to better understand the technical solutions in the embodiments of the present invention and to make the above objects, features and advantages of the present invention more comprehensible.
The endpoints of the ranges and any values disclosed herein are not limited to the precise range or value, and such ranges or values should be understood to encompass values close to those ranges or values. For ranges of values, between the endpoints of each of the ranges and the individual values, and between the individual values may be combined with each other to yield one or more new ranges of values, which ranges of values should be considered as specifically disclosed herein.
Example 1
A processing method of wall-broken ganoderma lucidum spore powder is characterized by comprising the following steps:
step S1, dissolving 10g of wall-broken ganoderma lucidum spore powder in 100mL of warm water in a container A, stirring, heating to boil, keeping for 2min under boiling condition, cooling to 70 ℃ at room temperature, centrifuging for 5min at 3000rpm, and absorbing supernatant into a container B;
step S2, placing the precipitate in a container A, adding 90mL of warm water, stirring, cooling to room temperature, adding 2g of porous starch, and stirring for 5min to enable the triterpenoids to be adsorbed to the porous starch;
step S3, pouring 1g of soluble dietary fiber and 0.2ml of honey into the supernatant in the container B, and stirring until the honey is completely dissolved;
step S4, cooling the honey water in the container B to room temperature, pouring the honey water into the container A, and uniformly stirring;
and step S5, drying and granulating the suspension to obtain the bitter-free ganoderma lucidum spore powder.
Example 2
A processing method of wall-broken ganoderma lucidum spore powder is characterized by comprising the following steps:
step S1, dissolving 20g of wall-broken ganoderma lucidum spore powder in 100mL of warm water in a container A, stirring, heating to boil, keeping for 3min under boiling condition, cooling to 75 ℃ at room temperature, centrifuging for 8min at 3000rpm, and absorbing supernatant into a container B;
step S2, placing the precipitate in a container A, adding 100mL warm water, stirring, cooling to room temperature, adding 5g porous starch, and stirring for 10min to enable the triterpenoids to be adsorbed to the porous starch;
step S3, pouring 2g of soluble dietary fiber and 1ml of honey into the supernatant in the container B, and stirring until the honey is completely dissolved;
step S4, cooling the honey water in the container B to room temperature, pouring the honey water into the container A, and uniformly stirring;
and step S5, drying and granulating the suspension to obtain the bitter-free ganoderma lucidum spore powder.
Example 3
A processing method of wall-broken ganoderma lucidum spore powder is characterized by comprising the following steps:
step S1, dissolving 15g of wall-broken ganoderma lucidum spore powder in 100mL of warm water in a container A, stirring, heating to boil, keeping for 3min under boiling condition, cooling to 72 ℃ at room temperature, centrifuging for 6min at 3000rpm, and absorbing supernatant into a container B;
step S2, placing the precipitate in a container A, adding 95mL warm water, stirring, cooling to room temperature, adding 4g porous starch, and stirring for 8min to enable the triterpenoids to be adsorbed to the porous starch;
step S3, 2g of soluble dietary fiber and 0.5ml of honey are poured into the supernatant in the container B and stirred until the honey is completely dissolved;
step S4, cooling the honey water in the container B to room temperature, pouring the honey water into the container A, and uniformly stirring;
and step S5, drying and granulating the suspension to obtain the bitter-free ganoderma lucidum spore powder.
Comparative example 1
The wall-broken ganoderma lucidum spore powder is ganoderma lucidum spore powder subjected to wall-breaking treatment, and other components are not added.
Comparative example 2
The processing method of the wall-broken ganoderma lucidum spore powder is to directly mix the wall-broken ganoderma lucidum spore powder and honey to prepare the wall-broken ganoderma lucidum spore powder.
Comparative example 3
The processing method of the wall-broken ganoderma lucidum spore powder is to mix the wall-broken ganoderma lucidum spore powder and the soluble dietary fiber.
Comparative example 4
In the processing method of the wall-broken ganoderma lucidum spore powder, on the basis of the example 1, the process of adding honey and soluble dietary fiber into the supernatant is eliminated, namely, porous starch is added into the precipitate, and the supernatant is discarded.
Comparative example 5
In the processing method of the sporoderm-broken ganoderma lucidum spore powder, honey is not added on the basis of the embodiment 1.
Comparative example 6
The processing method of the sporoderm-broken ganoderma lucidum spore powder provided by the embodiment cancels the addition of dietary fiber on the basis of the embodiment 1.
Comparative example 7
In the processing method of the wall-broken ganoderma lucidum spore powder, based on the embodiment 1, the porous starch is replaced by beta-cyclodextrin, and other technological parameters are unchanged.
The taste and sweetness of the wall-broken ganoderma lucidum spore powder prepared by the processing method of the wall-broken ganoderma lucidum spore powder of the embodiments 1 to 3 and the comparative examples 1 to 6 are evaluated, and the test results are as follows:
taste and sweetness assessment
Figure BDA0003496959800000051
Figure BDA0003496959800000061
Wherein "-" represents poor, unacceptable; "+" indicates poor and tolerable; "+ +" represents poor, but acceptable; "+ + + +" indicates that is more acceptable; "+ + + + +" indicates good.
The test results show that the wall-broken ganoderma lucidum spore powder prepared by the processing method of the wall-broken ganoderma lucidum spore powder has no bitter taste, moderate sweetness and good mouthfeel.
In the invention, the beta-cyclodextrin is adopted in the comparative example 7 to wrap the triterpenoid, although the taste can be improved, the beta-cyclodextrin is not easy to absorb, so that the effective components of the wrapped ganoderma lucidum spore powder can not be fully released in intestinal tracts, and further the effective components can not be fully digested and absorbed, thereby influencing the health care effect. Compared with beta-cyclodextrin, the invention adopts porous starch for coating, not only can better improve the taste of the ganoderma lucidum spore powder, but also has the characteristic of easy degradation, can improve the digestion and absorption effects of the active ingredients of the ganoderma lucidum spore powder in intestinal tracts, and further improves the medicinal effect of the ganoderma lucidum spore powder.
Compared with the prior art, the processing method of the wall-broken ganoderma lucidum spore powder has the beneficial effects that:
according to the processing method of the wall-broken ganoderma lucidum spore powder, porous starch is adopted to wrap triterpenoids in the ganoderma lucidum spore powder, wherein the porous starch has large specific surface area and specific pore volume and good water and oil absorption performance, and bitter triterpenoids in the ganoderma lucidum spore powder have hydrophobicity and can be better wrapped in the porous starch. The porous starch wraps bitter triterpenes, so that the direct action of bitter components of the wall-broken ganoderma spore powder and oral cavity can be reduced, and the bitter taste is reduced.
Secondly, according to the processing method of the wall-broken ganoderma lucidum spore powder, porous starch is adopted to wrap triterpenoids in the ganoderma lucidum spore powder, wherein the porous starch has a natural degradation effect, and the wrapped wall-broken ganoderma lucidum spore powder is orally taken, so that the porous starch is digested in intestinal tracts, active ingredients of the ganoderma lucidum spore powder are digested and absorbed in the intestinal tracts, and the health-care effect of the ganoderma lucidum spore powder is improved.
Third, the processing method of the wall-broken ganoderma lucidum spore powder provided by the invention adds the soluble dietary fiber and the honey to adjust the taste of the ganoderma lucidum spore powder, has the effect of relaxing bowel, and can well overcome the constipation phenomenon of some people by being compatible with the ganoderma lucidum spore powder.
The embodiments of the present invention have been described in detail, but the present invention is not limited to the described embodiments. Various changes, modifications, substitutions and alterations to these embodiments will occur to those skilled in the art without departing from the spirit and scope of the present invention.

Claims (2)

1. A processing method of wall-broken ganoderma lucidum spore powder is characterized by comprising the following steps:
step S1, dissolving 10-20g of wall-broken ganoderma lucidum spore powder in 100mL of warm water in a container A, heating to boiling after stirring, keeping for 2-3min under the boiling condition, cooling to 70-75 ℃ at room temperature, centrifuging for 5-8min at the rotating speed of 3000rpm, and sucking supernatant into a container B;
step S2, placing the precipitate in a container A, adding 90-100mL of warm water, stirring, cooling to room temperature, adding 2-5g of porous starch, and stirring for 5-10min to enable the triterpenoids to be adsorbed to the porous starch;
step S3, pouring 1-2g of soluble dietary fiber and 0.2-1ml of honey into the supernatant in the container B, and stirring until the honey is completely dissolved;
step S4, cooling the honey water in the container B to room temperature, pouring the honey water into the container A, and uniformly stirring;
and step S5, drying and granulating the suspension to obtain the bitter-free ganoderma lucidum spore powder.
2. The processing method of the sporoderm-broken ganoderma lucidum spore powder according to claim 1, which is characterized by comprising the following steps:
step S1, dissolving 10g of wall-broken ganoderma lucidum spore powder in 100mL of warm water in a container A, stirring, heating to boil, keeping for 2min under boiling condition, cooling to 70 ℃ at room temperature, centrifuging for 5min at 3000rpm, and absorbing supernatant into a container B;
step S2, placing the precipitate in a container A, adding 90mL of warm water, stirring, cooling to room temperature, adding 2g of porous starch, and stirring for 5min to enable the triterpenoids to be adsorbed to the porous starch;
step S3, pouring 1g of soluble dietary fiber and 0.2-1ml of honey into the supernatant in the container B, and stirring until the honey is completely dissolved;
step S4, cooling the honey water in the container B to room temperature, pouring the honey water into the container A, and uniformly stirring;
and step S5, drying and granulating the suspension to obtain the bitter-free ganoderma lucidum spore powder.
CN202210120270.0A 2022-02-08 2022-02-08 Processing method of wall-broken ganoderma lucidum spore powder Pending CN114404461A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210120270.0A CN114404461A (en) 2022-02-08 2022-02-08 Processing method of wall-broken ganoderma lucidum spore powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210120270.0A CN114404461A (en) 2022-02-08 2022-02-08 Processing method of wall-broken ganoderma lucidum spore powder

Publications (1)

Publication Number Publication Date
CN114404461A true CN114404461A (en) 2022-04-29

Family

ID=81278470

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210120270.0A Pending CN114404461A (en) 2022-02-08 2022-02-08 Processing method of wall-broken ganoderma lucidum spore powder

Country Status (1)

Country Link
CN (1) CN114404461A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09252744A (en) * 1996-03-26 1997-09-30 Sanei Touka Kk Powder containing extract of gymnema sylvestre r. br. and its production
CN106234510A (en) * 2016-07-28 2016-12-21 合肥吴复和食品有限公司 A kind of Rhizoma Dioscoreae Pericarpium Citri Reticulatae cake of constipation relieving
US20200147159A1 (en) * 2017-10-16 2020-05-14 Zhejiang Shouxiangu Pharmaceutical Company, Ltd. Bitter ganoderma lucidum spore powder and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09252744A (en) * 1996-03-26 1997-09-30 Sanei Touka Kk Powder containing extract of gymnema sylvestre r. br. and its production
CN106234510A (en) * 2016-07-28 2016-12-21 合肥吴复和食品有限公司 A kind of Rhizoma Dioscoreae Pericarpium Citri Reticulatae cake of constipation relieving
US20200147159A1 (en) * 2017-10-16 2020-05-14 Zhejiang Shouxiangu Pharmaceutical Company, Ltd. Bitter ganoderma lucidum spore powder and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
柴玉: "孢子粉:苦的才是好的", 《中医健康养生》 *

Similar Documents

Publication Publication Date Title
KR101924903B1 (en) A method of manufacturing a herbal medicine pill that has the effect of improving vaginal immunity and treating chronic vaginitis
AU2014258206B2 (en) Cereal containing hericium erinaceum and method for making same
CN107518133A (en) A kind of relieving alcoholism and protecting liver jasmine tea and preparation method thereof
CN105250997A (en) Composition used for dispelling effects of alcohol and protecting liver, and preparation method thereof
KR20130014766A (en) Oriental medicine composition for curing rhinitis in children and manufacturing method thereof
CN103766905A (en) Dendrobium candidum-chuzhou chrysanthemum health-care granule
CN114404461A (en) Processing method of wall-broken ganoderma lucidum spore powder
CN104873446B (en) A kind of toothpaste containing cinnamon oil
CN105031289A (en) Dendrobium officinale and lucid ganoderma capsules and preparation method thereof
CN108084292A (en) A kind of method that senile hyperlipidemia polysaccharide is treated in extraction from black fungus
CN106173155A (en) A kind of Herba Dendrobii soft sweet and preparation method thereof
CN104888070A (en) Drug formulation for treating respiratory internal pulmonary tuberculosis and manufacture method thereof
CN112076266A (en) Ganoderma lucidum spore powder buccal tablet and preparation method thereof
CN101461906A (en) Health product with function for removing liver-fire and improving eyesight as well as preparation method thereof
CN111494554A (en) Dendrobium wine and preparation method of dendrobium anti-alcohol liquid
CN104491359B (en) It is a kind of to treat canker sore, Chinese medicine composition that pharyngitis swells and ache and preparation method thereof
CN107980863A (en) A kind of production method of mulberry leaf wild chrysanthemum fried dough twist
KR20220044055A (en) Composition for Preventing, Improving, or Treating Alcoholic Gastrointestinal Disease comprising Yeast Extract as an Active Ingredient
CN105664133A (en) Oral solid preparation for treating hypertension and preparing method thereof
CN110522883A (en) One kind controlling tinea pedis selenium-rich Chinese medicine composition and preparation method thereof
WO2020029314A1 (en) Brewing method for radix notoginseng red rice yeast vinegar
CN114271437B (en) Fine dried noodles with slow digestion function and preparation method thereof
CN104189489A (en) Medicament with effect of treating chronic eczema and preparation method thereof
CN106387589A (en) Edible mushroom solid beverage for treating chronic pharyngitis
CN107007731A (en) A kind of Chinese medicine composition and preparation method for treating conjunctivitis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination